215 related articles for article (PubMed ID: 14552431)
1. Hodgkin and non-Hodgkin lymphoma involving bone marrow.
Viswanatha D; Foucar K
Semin Diagn Pathol; 2003 Aug; 20(3):196-210. PubMed ID: 14552431
[TBL] [Abstract][Full Text] [Related]
2. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow biopsy in staging malignant lymphoma.
Mehta JB; Singhal SB; Mehta BC
J Assoc Physicians India; 1990 Oct; 38(10):818, 821. PubMed ID: 2084104
[No Abstract] [Full Text] [Related]
4. [Bone marrow biopsy in the staging of malignant lymphoma].
Cohen Y; Vider S; Menster J; Ben-Arie J
Harefuah; 1978 May; 94(9):273-4. PubMed ID: 580929
[No Abstract] [Full Text] [Related]
5. [Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].
Liu EB; Chen HS
Ai Zheng; 2005 Nov; 24(11):1416-20. PubMed ID: 16552975
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology.
Duggan PR; Easton D; Luider J; Auer IA
Cancer; 2000 Feb; 88(4):894-9. PubMed ID: 10679660
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy.
Fend F; Kremer M
Pathobiology; 2007; 74(2):133-43. PubMed ID: 17587884
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow biopsy in staging of malignant lymphomas.
Singh T; Harjinder ; Gaiha M
J Assoc Physicians India; 1989 Aug; 37(8):513-4. PubMed ID: 2621187
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
Zhang QY; Foucar K
Hematol Oncol Clin North Am; 2009 Aug; 23(4):873-902. PubMed ID: 19577173
[TBL] [Abstract][Full Text] [Related]
10. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non-Hodgkin lymphoma.
Douglas VK; Gordon LI; Goolsby CL; White CA; Peterson LC
Am J Clin Pathol; 1999 Dec; 112(6):844-53. PubMed ID: 10587708
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
13. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
14. Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information.
Nardi V; Pulluqi O; Abramson JS; Dal Cin P; Hasserjian RP
Am J Hematol; 2015 Jun; 90(6):529-33. PubMed ID: 25776302
[TBL] [Abstract][Full Text] [Related]
15. Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma.
Crotty PL; Smith BR; Tallini G
Diagn Mol Pathol; 1998 Apr; 7(2):90-5. PubMed ID: 9785007
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic evaluation of the bone marrow in non-Hodgkin's lymphoma.
Fineberg S; Marsh E; Alfonso F; Espiritu E; Gottesman SR; Amorosi E; Feiner HD
Hum Pathol; 1993 Jun; 24(6):636-42. PubMed ID: 8505041
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Features of Bone Marrow Infiltration in Hodgkin Lymphoma. Should Bone Marrow Staging Be Done Only in High Risk Patients?
Sudalaimuthu M; Basu D
Turk Patoloji Derg; 2017; 33(2):129-133. PubMed ID: 28272679
[TBL] [Abstract][Full Text] [Related]
18. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques.
Pittaluga S; Tierens A; Dodoo YL; Delabie J; De Wolf-Peeters C
Am J Clin Pathol; 1999 Feb; 111(2):179-84. PubMed ID: 9930138
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow manifestations of malignant lymphoma and lymphoma-like conditions.
Brunning RD; McKenna RW
Pathol Annu; 1979; 14 Pt 1():1-59. PubMed ID: 390475
[No Abstract] [Full Text] [Related]
20. Bone marrow trephine biopsy in lymphoproliferative disease.
Schmid C; Isaacson PG
J Clin Pathol; 1992 Sep; 45(9):745-50. PubMed ID: 1401199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
